Jialiang Brain Science Partners with National Neurological Medical Center to Advance Brain-Computer Interface Therapy for Epilepsy
GenLight
Innovative Medical Device Solution Provider
On September 27, byNational Neurological Disease Regional Medical Center, Xuanwu Jinan Center、Xuanwu Hospital of Capital Medical University, Jinan HospitalUnitedBeijing Neuroscience SocietyHosted by "The First Quancheng Brain-Computer Interface Innovation Forum"Successfully held in Jinan.
This forum brings together many experts and scholars in the fields of neuroscience, brain-computer interface, and neuromodulation in China to jointly discuss the latest advancements in brain-computer interface technology and clinical transformation pathways. At the same time, the "National Neurology Jinan Medical Center Brain-Computer Interface Innovation Alliance". Genlight Neurotech, an innovative company specializing in precise treatment of epilepsy, was invited to participate in this grand event.
Focus on the Frontier:
Dr. Peng Cao Invited to Share Progress in Medical Innovation and Commercialization
At the thematic forum following the alliance's inauguration ceremony, Dr. Peng Cao, General Manager of Genlight Neurotech, delivered a keynote speech titled "Innovation and Commercialization Progress of Brain-Computer Interface-Based Devices for Treating Refractory Epilepsy," introducing the company’s independently developed innovations.Implantable Closed-Loop Self-Responsive Neurostimulation System Epilcure™。This system has high-resolution signal perception and intelligent response capabilities, which can monitor brain neural electrical activity in real time. During epileptic seizures, it accurately delivers electrical stimulation to effectively block abnormal discharges, achieving "on-demand treatment." This not only greatly improves treatment efficiency but also significantly reduces potential side effects of traditional treatment methods.
From Lab to Bedside: Commercialization Process Accelerates
In addition to technological breakthroughs, Dr. Cao Peng also highlighted the commercial progress of this innovative device. He stated that product development is advancing at full speed and has now entered the final stage of clinical registration.
Join Hands with Ecosystem Partners to Promote the Clinical Application of Brain-Computer Interface
During the forum discussion session, Dr. Peng Cao stated that Genlight Neurotech is willing to deepen cooperation with top domestic clinical centers for neurological diseases such as Xuanwu Hospital, jointly build an "integration of medicine and engineering" innovation platform, accelerate the transformation of brain-computer interface products from technology to product, and promote domestically produced neuro-modulation devices to serve a wide range of patients as soon as possible.
Genlight Neurotech upholds the mission of "Innovating to Safeguard Brain Health," focusing on the research and development of high-end medical devices in the fields of brain science and neuromodulation. It is committed to providing innovative treatment solutions for neurological disorders such as epilepsy and Parkinson's disease. With the responsibility of "Made in China," the company continuously promotes the clinical translation and industrial development of domestically produced brain-computer interface technology.
